.jpg "Jocelyn H. Leu, PharmD, PhD photo")
Scientific Director
Janssen Pharmaceuticals
Jocelyn H Leu, PharmD, PhD is a Scientific Director in the Clinical Pharmacology and Pharmacometrics group at Janssen Research and Development supporting the Immunology Therapeutic Area. Her focus at Janssen is mainly in rheumatologic and autoantibody related diseases and has worked on Simponi, Simponi Aria, Stelara and Tremfya as well as some early development compounds. In addition to representing and supporting early to late stage drug development from the clinical pharmacology standpoint, she is also part of the Immunology Pediatric Development Team. In recent years, her focus has been on pediatric development in pJIA, jPsA and type 1 diabetes, combination products (monoclonal antibody + device) as well as immunogenicity of therapeutic proteins. Prior to Janssen, she worked at then called Abbott (now Abbvie) on Humira and Orlissa. Prior to Abbott, she worked at Kos Pharmaceuticals (which was acquired by Abbott) on combination niacin/statin products and inhaled insulin. Jocelyn received her concurrent PharmD and PhD at Virginia Commonwealth University under the direction of Dr. Jürgen Venitz, MD, PhD.
.png)